BC30™ Obtains Approval to Display "Live Culture" Claims in Indonesia, Opening Opportunities for Food and Beverage Product Innovation
Jakarta, Indonesia – BC30™ from Kerry (Bacillus coagulans GBI-30, 6086), a spore-form probiotic ingredient capable of surviving in the digestive system, has obtained approval in Indonesia to display “Live Culture” claims on applicable general food categories. The approval was granted to Kerry after BC30™ was included in the list of permitted microorganisms in Indonesia under PERBPOM No. 38/2023, a regulation governing the microorganisms permitted for use in processed foods in Indonesia.
Products containing BC30™ may now display “Live Culture” claims on packaging and marketing materials whilst complying with the requirements of the Drug and Food Authority (BPOM). The approval applies to the general food category, with the exception of Category 13.0 – Specialised Nutrition Products, which is regulated separately under Indonesia’s food category framework.
“This BPOM approval represents an important step for producers wishing to develop credible functional foods that comply with Indonesian regulations,” said Olivier De Salmiech, Vice President, Health & Therapies, Kerry Asia Pacific, Middle East & Africa. “The ability to display ‘Live Culture’ claims with BC30™ on product packaging opens new opportunities for us to meet consumer interest in maintaining digestive health, whilst maintaining the formulation stability and quality required in food and beverage applications.”
According to consumer research conducted by Kerry, digestive health has become the leading functional health requirement globally. Some 76% of consumers believe that gut health influences overall physical and mental health and wellbeing. In Southeast Asia, consumers increasingly seek functional food and beverage products that support daily digestive health.
Designed for food and beverage applications, BC30™ (Bacillus coagulans GBI 30, 6086) is recognised as an ingredient that remains stable during production, storage, and digestion processes, thereby ensuring that live cultures reach the digestive tract.
To meet the requirements for “Live Culture” claims in Indonesia, products containing BC30™ must comply with several provisions under key regulations. These include displaying the full genus, species, and strain name – Bacillus coagulans GBI 30, 6086 – in the product composition list. The final product must also contain a minimum of 1 × 10⁶ colony-forming units (CFU) per gram or millilitre at the end of shelf life, supported by relevant analytical data. Additionally, products must clearly display storage instructions to meet BPOM requirements.
The approval obtained by BC30™ reinforces Kerry’s commitment to supporting science and regulation-based innovation in developing functional food and beverage products specifically designed for local market needs.